We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ISRG:NASDAQIntuitive Surgical, Inc. Analysis

Data as of 2026-03-09 - not real-time

$493.56

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Intuitive Surgical continues to deliver robust top‑line growth and strong profitability, with revenue expanding at a healthy pace and margins remaining well above industry averages. Operating cash flow and free cash flow are solid, supporting ongoing investment in technology and expansion. However, the stock trades at a premium valuation, with a price‑earnings multiple far exceeding the sector average and a discounted cash‑flow estimate suggesting the market price is substantially above intrinsic value. Technical indicators show a neutral price trend, a bullish MACD histogram, and a support level that is comfortably above recent lows, while volatility remains elevated. Recent material news highlights the completion of a European distribution acquisition, positioning the company for direct market presence abroad, and an earnings beat that reinforced confidence in its growth trajectory. The combination of high growth potential, premium pricing, and heightened volatility frames the current investment landscape for ISRG.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Neutral technical trend with price near support
  • Elevated short‑term volatility
  • Overvalued relative to fundamentals

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Sustained revenue growth and strong operating margins
  • Strategic European expansion increasing addressable market
  • Earnings beat reinforcing growth outlook

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Durable competitive moat from the da Vinci platform
  • High cash generation supporting R&D and acquisitions
  • Long‑term demand for minimally invasive surgical solutions

Key Metrics & Analysis

Financial Health

Revenue Growth18.80%
Profit Margin28.38%
P/E Ratio62.6
ROE16.69%
ROA9.39%
Debt/Equity0.95
P/B Ratio9.8
Op. Cash Flow$3.0B
Free Cash Flow$2.3B
Industry P/E25.4

Technical Analysis

TrendNeutral
RSI43.4
Support$475.83
Resistance$511.88
MA 20$496.21
MA 50$522.86
MA 200$512.50
MACDBullish
VolumeStable
Fear & Greed Index100

Valuation

Fair Value$208.63
Target Price$609.82
Upside/Downside23.56%
GradeOvervalued
TypeGrowth

Risk Assessment

Beta1.16
Volatility24.76%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.